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Abstract  
Background: Placenta previa is one of the causes of antepartum hemorrhage. It contributes to maternal death. 
Hence, this study assessed the magnitude of placenta previa and its associated factors among women admitted with 
antepartum hemorrhage at Hawassa University comprehensive specialized hospital. 
Methods: A facility-based retrospective cross-sectional study was conducted among 300 pregnant women admitted 
with antepartum hemorrhage at Hawassa University comprehensive specialized hospital. A simple random sample 
technique was used to select a woman’s charts.  Data were collected using a pre-tested checklist. Data were analyzed 
using statistical software. Bivariable and multivariable logistic regression analyses were done to identify the factors 
associated with placenta previa. A P-value of less than 0.05 was considered as statistically significant.  
Results: The prevalence of placenta previa among mothers with antepartum hemorrhage was 60.3% (95% CI: 57.8, 
62.4). The major adverse maternal outcomes identified were cesarean delivery 175 (96.4%), hypovolemic shock 
82(45.3%), and blood transfusion 92(50.8%). Those mothers with gravidity of 2-4 (AOR=3.40; 95% CI: 1.39,8.31) 
and >5 ( AOR=5.67; 95% CI: 2.11,15.20), gestational age of 28-33 weeks (AOR=3.83; 95% CI: 1.77, 4.65), 34-36 
weeks (AOR=2.45; 95% CI: 1.30, 4.56), having previous caesarean section scar (AOR=3.27; 95% CI: 1.26, 8.50), 
and having  a male fetus gestation (AOR=3.49; 95% CI: 1.26, 8.50) had a more likelihood of developing placenta 
previa than their counterparts.  
Conclusion: About two-thirds of the cases admitted with the diagnosis of antepartum hemorrhage were caused by 
placenta previa. Previous cesarean section, gravidity, male sex, and gestational age were the factors identified for 
placenta previa. Efforts should be made to reduce the rate of pregnancy and cesarean delivery through improving the 
provision of family planning to decrease the magnitude of placenta previa. 
 
Keywords: Hawassa, placenta previa, Southern Ethiopia  
How to cite: Elias, S., Amano, A. and Wakgari, N. 2020. Placenta Previa and its Associated Factors among Women Admitted with Antepartum 
Haemorrhage in Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia. East African Journal of Health and Biomedical 
Sciences, Volume 4 (2): 39-46 
 
Introduction  
Placenta previa when the placenta is implanted in the 
lower uterine segment (Walfish et al., 2009; Cun-
ningham et al., 2014; Sakornbut et al., 2007; Oyelese 
and Smulian, 2006). It can be associated with mas-
sive blood loss at delivery thereby which increase the 
risk of antepartum, intrapartum, and postpartum 
hemorrhage. It can also result in significant loss of 
intravascular volume which can lead to hemody-
namic instability, decreased oxygen perfusion, cellu-
lar hypoxia, and organ damage (Sachayta et al, 2019; 
Sarojini et al, 2016). 
Studies have also proved that placenta previa is the 
main cause of antepartum hemorrhage and a con-
tributing factor to maternal morbidity and mortality 
worldwide (Chufamo et al., 2015; Berhan, 2014; 
Wasnik and Naiknaware, 2015; Anzaku and Musa, 
2010; Raees et al., 2015).  About 0.03 to 1% mater-
nal deaths were contributed by placenta previa in the 
previous studies (Sachayta et al, 2019; Bose et al, 
2011). It is believed that diagnosis and active peri-
partum management can reduce morbidity and mor-
tality related to placenta previa (Walfish et al., 2009; 
Cunningham et al., 2014). Antepartum haemorrhage 
complicates 2-5% of pregnancies and it is mainly 
caused by placenta previa (Sakornbut et al., 2007; 
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Ahmed et al., 2015).  About 51.6% of antepartum 
hemorrhage is caused by placenta Previa (Fan et al., 
2017). Similarly, it is found to be the major cause 
antepartum hemorrhage in the previous studies con-
ducted in different parts of Ethiopia: Jimma (26.7%), 
Addis Ababa (0.7%) and Hawassa (58.6%)  (Chu-
famo et al., 2015; Berhan, 2014; Adere et al., 2020). 
It is believed that diagnosis and active peri-partum 
management can reduce morbidity and mortality re-
lated to placenta previa (Walfish et al., 2009; Cun-
ningham et al., 2014). 
Different factors were identified related to placental 
Previa. Some factors such as advanced maternal age, 
multiparty, and history of caesarean delivery were 
identified to be associated with placenta Previa 
(Adere et al., 2020; Sarojini et al., 2016).  
Many previous studies have reported placenta previa 
as a major factor of obstetric hemorrhage and its as-
sociated factor including from Ethiopia (Chufamo et 
al., 2015; Berhan, 2014; Adere et al., 2020). How-
ever, they did not provide conclusive evidence. Even, 
there is no documented report about the magnitude 
and associated factors of placenta previa in Hawassa. 
Therefore, this study assessed placenta previa and its 
associated factors among women admitted with ante-
partum hemorrhage to the obstetric ward of Hawassa 
University Comprehensive Specialized Hospital.  
Materials and Methods 
Study setting  
A facility-based retrospective cross-sectional study 
was conducted among women admitted with the di-
agnosis of antepartum hemorrhage to obstetric ward 
of Hawassa University Comprehensive Specialized 
Hospital (HUCSH) from June 1-15, 2017. Hawassa is 
the capital city of the Southern Nation, Nationality, 
and People Region (SNNPR). It is located 273 Km 
from Addis Ababa. Hawassa University Comprehen-
sive Specialized Hospital is the referral hospital in 
the region, serving as a teaching hospital for the 
College of Medicine and Health Sciences, with a 
catchment population of 18 million. It has seven de-
partments Gynaecology and obstetrics is one of the 
departments where labouring mothers are admitted, 
followed, and managed accordingly. There are 73 
beds in the gynaecology and obstetrics department 
(53 in gynecology and obstetrics ward, 13 in postna-
tal and 7 in labour ward) and 4 delivery coaches. 
Population  
All the mothers who gave birth after 28 weeks of 
gestation and who had antepartum hemorrhage were 
the study population. Maternal medical record/charts 
that were lost or incomplete and mothers died on ar-
rival were excluded from the study. In addition, the 
women having any co-morbidity such as cardiac 
problems, hypertension, renal diseases, diabetes 
mellitus, systemic lupus erythematous, and goiter 
were also excluded.  
Sample size determination and sampling proce-
dure 
The sample size was determined using single popula-
tion proportion formula by using proportion (p) 
26.7% from the previous study (Chufamo et al., 
2015), 95% confidence level, 5% margin of error, 
and 10 % non-response rate. The final sample size 
was 300. The registration numbers of all the mothers 
who had atepartum hemorrhages and gave birth at 
HUCSH for five years (January 1, 2012, to December 
30, 2016) were traced from the hospital’s delivery log 
book registry and then listed down to form a sam-
pling frame. Among the total of 435 mothers who 
were diagnosed to have APH during the study period, 
data of 428 mothers were found to be eligible for the 
study, and each chart was numbered. Then, by simple 
random sample technique (using a computer-gener-
ated random number), 300 charts were selected.  
Data collection method   
Data were collected using a pre-tested checklist pre-
pared in English by an integrated emergency surgical 
officer. The checklist consists of socio-demographic 
variables, obstetric history, medical history, and ma-
ternal outcome after the management of placenta 
previa.  
Data quality control 
The checklist was pre-tested on 30 charts at Yerga-
lem General Hospital before assessing for clarity, 
flow, and construction. Questions that were found 
unclear or confusing were modified, reconstructed, or 
discarded. Intensive training was given to the data 
collectors and supervisor on how to conduct the data 
collection. The collected data were checked daily for 
completeness by the supervisor.   
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Data analysis 
The data were entered into Epi info and exported to 
SPSS Version 20 for analysis. Frequencies and cross-
tabulations were used to summarize descriptive sta-
tistics. Bivariable and multivariable logistic regression 
analyses were done to identify factors associated with 
placenta previa. Variables with p < 0.25 in the bivari-
ate analysis were entered into the multivariable anal-
ysis. In multivariable analysis, those variables with P 
< 0.05  at 95% confidence interval were considered 
as significantly associated factors with placenta pre-
via.  
Ethical consideration 
Ethical clearance was obtained from the Institutional 
Review Board of the College of Medicine and Health 
Science, Hawassa University with an ethical number 
of IRB/008/2017. Permission from hospital administra-
tors of HUCSH was obtained through a formal letter 
from the University. Then, the purpose and objective 
of the study were introduced to the head of the gy-
naecology and obstetrics department and the hospital 
medical director. Confidentiality information was 
kept like the patient’s name was not included in the 
checklist. After finishing the data collection, the pa-
tients’ charts were returned to the card room. Infor-
mation obtained during data collection was only used 
for this study purpose. 
Results 
Socio-demographic characteristics 
The mean age of the study participants was 
28.2(±5.9) years. The youngest and oldest mothers 
were 18 and 40 years, respectively. One-hundred 
eighty (60%) mothers were from rural areas. 
Obstetric history of the mothers 
 A total of 125 (41.7%) study participants with APH 
were grandmultipara (gave birth more than five 
times). Forty-seven (15.7%) of the study participants 
had an abortion. Most of the study participants devel-
oped APH in the gestational age of 28-34 weeks. 
Many of the study participants 238(79.3%) had ante-
natal care follow up. Cesarean section was the most 
common route of delivery, 252(84%). Similarly, 
45(15%) of the study participants had previous cae-
sarean section scar and 147(49%) of them had a male 
fetus gestation (Table 1). 
 
Table 1: Obstetric history of study participants at Hawassa University Comprehensive Specialized Hospital, January 
1, 2012, to December 30, 2016 (n=300). 
Variables Frequency  Percent (%) 
Gravidity    
     Primigravida 45 15 
     2-4 130 43.3 
     ≥5 125 41.7 
Abortion   
     Yes  47 15.7 
     No  253 84.3 
Gestational age   
     28-33 101 33.7 
     34-36 72 24 
     ≥37 127 42.3 
Antenatal care   
     Yes  238 79.3 
     No  62 20.7 
Previous cesarean section scar   
     Yes  45 15 
     No  255 85 
Previous placenta previa   
     Yes  9 3 
     No  291 97 
Sex of pregnancy   
     Male 147 49 
     Female   153 51 
Number of gestation    
     Singleton 290  96.7 
     Multiple 10 3.3 
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Prevalence and types of placenta previa 
During the five years of the study period, 9,123 pa-
tients gave birth in HUCSH. Out of these, 300 moth-
ers with APH included in the current study. The 
commonest cause of APH was placenta previa 181 
(60.3%) (95% CI: 57.8, 62.4) and abruption placenta, 
98 (32.7%).  Moreover, about 21(7%) of them were 
caused by the bloody show, uterine rupture, cervical 
lesions, or unknown causes. Placenta previa totalis 
was the most common type of placenta previa 
11(65.9%) in relation to cervical os. With respect to 
presenting part of the fetus, posterior placenta previa 
was the prevalent one 92(51.1%), followed by ante-
rior type 76(41.7%), and lateral placenta previa, 13 
(7.2%). 
Adverse maternal outcome  
In this study, 175(96.4%) of the placenta previa cases 
were undergone cesarean delivery while 6(3.6%) of 
them gave birth spontaneously. About 82(45.3%) of 
them developed hypovolemic shock. On the other 
hand, 92(50.8%) of them were transfused with blood; 
and 8(4.4%) of them were done peripartum hyster-
ectomy.  Among those undergone peripartum hyster-
ectomy, 5(2.8%) of them were for an indication of 
placenta accerta.  Likewise, respiratory failure was 
also reported in 5(2.8%) of the women (Table 2). 
Table 2: Adverse maternal outcome of subjects with placenta previa at Hawassa University Comprehensive Spe-
cialized Hospital, January 1, 2012, to December 30, 2016(n=181). 
Variables Frequency Percent (%) 
Aspiration pneumonia 1 0.55 
Hospital-acquired pneumonia 1 0.55 
Sepsis 1 0.55 
Intensive care unit admission 3 1.7 
Placenta accerta 5 2.8 
Respiratory failure 5 2.8 
Acute kidney injury 6 3.3 
Puerperal sepsis 7 3.5 
Peripartum hysterectomy 8 4.4 
Postpartum haemorrhage 11 6.1 
Malpresentation 14 7.7 
Expectant management 32 17.7 
Hypovolemic shock 82 45.3 
Blood transfusion 92 50.8 
Death 1 0.6 
Factors associated with placenta previa 
In the bivariate analysis, age, gravidity, history of 
abortion, history of previous cesarean section scar, 
history of previous placenta previa, gestational age, 
sex of pregnancy, and the number of gestation were 
candidates for multivariable analysis. In multivariable 
analysis, gravidity, gestational age of the pregnancy, 
previous cesarean section scar, and sex fetus re-
mained associated with placenta previa in multivaria-
ble analysis.  Accordingly, mothers with gravidity of 
>5 almost 6 times (AOR=5.67; 95% CI: 2.11, 15.20) 
and 2-4 more than 3 times (AOR=3.40; 95% CI: 
1.39, 8.31) more likely to develop placenta previa as 
compared to those with prim gravidity.  
 
Furthermore, the women with the gestational age of 
28-33 were almost 4 times (AOR=3.83; 95% CI: 
1.77, 4.65) and 34-36 more than 2 times (AOR=2.45; 
95% CI: 1.30, 4.56) more likely to develop placenta 
previa as compared to the women with the gestational 
age of >37 weeks. Those mothers having previous 
cesarean section scar were three times more likely to 
develop placenta previa than their counterpart 
(AOR=3.27; 95% CI: 1.26, 8.50).  Moreover, the 
mothers with a male fetus gestation were found to be 
four times more likely to have placenta previa as 
compared to those mothers having a female gestation 
(AOR=3.68;  95% CI: 2.07, 6.52) (Table 3). 
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Table 3: Associated factors of placenta previa, HUCSH, January 1, 2012, to December 30, 2016 (n=300). 
Variables Placenta previa COR (95% CI)       AOR (95%CI) 
 Yes  
No (%)  
No  
No (%) 
  
Age      
     ≤20 13(4.3)        24(8) 1 1 
     21-34  61(20.3)      15(5) 7.50(3.11-18.10) 3.46(0.17-10.26) 
     ≥35 107(35.7)      80(26.7) 2.47(1.18-5.15) 2.00(0.84-4.80) 
Gravidity     
     Primigravida 9(3) 36(12) 1 1 
     2-4 76(25.3)    54(18) 5.63(2.50-12.65)            3.40(1.39-8.31) * 
     ≥5 96(32)         29(9.7) 13.24(5.72-30.68)          5.67(2.11-15.20) * 
Abortion     
     Yes  36(12)  11(3.7) 2.44(1.18-5.00)              1.30(0.56-2.96) 
     No  145(48.3)     108(36) 1 1 
Gestational age     
     28-33 70(23.3)      31(10.3) 3.05(1.76-5.29) 3.83(1.77-4.65) * 
     34-36 57(19) 15(5) 5.14(2.63-10.02) 2.45(1.30-4.56)* 
     ≥37 54(18) 73(24.3) 1 1 
Previous cesarean section scar     
     Yes  35(11.7)     10(3.3) 2.62(1.24-5.50  3.27(1.26 -8.50) * 
     No  146(48.7)     109(36.3) 1 1 
Sex of fetus     
     Male 116(38.7)       31(10.3)                      5.07(3.04-8.43)              3.68(2.07- 6.52)* 
     Female   65(21.7)          88(29.3) 1 1 
*: Significant in backward stepwise logistic regression; COR: Crude Odd Ratio; AOR: Adjusted Odd Ratio; CI: Confidence 
interval 
Discussion 
The prevalence of placenta previa among mothers 
with antepartum hemorrhage was 60.3% (95% CI: 
57.8, 62.4). Gravidity, gestational age of the preg-
nancy, previous cesarean section scar, and sex fetus 
were the factors identified for placenta previa. In this 
study, adverse maternal outcomes such as blood 
transfusion, postpartum hemorrhage, hypovolemic 
shock, peripartum hysterectomy, acute kidney injury, 
respiratory failure, sepsis, admission to intensive care 
unit, and deaths were identified. An adverse maternal 
outcome identified in the present study is in line with 
the existing literatures of developing countries (Was-
nik and Naiknaware, 2015;Anzakuand Musa, 
2010;Raees et al., 2015; Adereet al., 2020;Singhal et 
al., 2008;Crane et al.,2000).  
The prevalence of placenta previa among mothers 
with APH in the last five years of the study period 
was 60.3%. This finding is comparable with the pre-
vious finding in Ethiopia (58.6%) (Berhan, 2014).  
Those mothers with a high number of gravidity were 
more likely to develop placenta previa as compared 
with mothers with less number of gravidity. This is in 
agreement with different study findings (Anzaku and 
Musa, 2010; Faiz and Ananth, 2003; Kedar et al., 
2016; Burodo and Shehu, 2013; Eniola, 2002; Pari-
jchatt and Tongswatwong, 2009; Senkoro et al., 
2017). This might be because as the number of preg-
nancy increases, the probability of the occurrence of 
placenta previa's risk factor such as uterine scar and 
abortion might also increase the occurrence placenta 
previa’s (Wasnik and Naiknaware, 2015; Adere et 
al., 2020; Parijchatt and Tongswatwong, 2009; 
Senkoro et al., 2017; Majeed et al., 2015). 
Early gestational age is also found to be an important 
factor of placenta previa. As gestational age in-
creases, the occurrence of placenta previa decreases. 
This finding is consistent with previous study find-
ings (Anzaku and Musa, 2010; Ananthet al., 2003). 
This might be due to the physiological migration of 
the placenta which could be explained by the devel-
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opment of the lower uterine segment in late gesta-
tional age. This means a woman who is claimed to 
have placenta previa at earlier gestation age might 
not have placenta previa at late gestation (Strong and 
Brar, 1989; Neilson, 2003). 
Those mothers having previous cesarean section scar 
had a more likely to develop placenta previa than 
those mothers without cesarean section scar. This is 
comparable with studies conducted in India, and Ni-
geria (Wasnik and Naiknaware, 2015; Anzaku and 
Musa, 2010). The Cesarean section might cause dam-
age to endothelial lining (decidual layer) and result in 
scarring of the uterus. The attraction and adherence 
of the placenta to the cesarean section scar can also 
be a reason for the lower implantation of the placenta 
in subsequent pregnancies (Oya et al., 2008). 
This study also found that male sex fetus was an as-
sociated factor of placenta previa. The pathophysi-
ologic mechanism explaining the association between 
placenta previa and male sex gestations is unknown. 
However, it might be because early and late insemi-
nation during the menstrual cycle may cause an in-
crease in male conception and also cause to change 
the site of implantation (Faiz and Ananth, 2003; De-
missie, 1999).  
The source of the data for this study was a record 
review. Thus, some socio economic-related factors 
cannot be assessed and some charts were also incom-
plete. In addition, those variables significantly asso-
ciated with placenta previa need to be cautiously in-
terpreted as the data were a record review with a po-
tential lack of other relevant factors. 
Conclusion 
About two-thirds of the cases admitted with the diag-
nosis of antepartum hemorrhage were caused by pla-
centa previa. Those women with a previous increased 
number of gravidity, earlier gestational age, cesarean 
section scar, having a male sex fetus were factors 
identified to be associated with the occurrence of 
placenta previa. Pregnant mothers should receive 
antenatal care follow up at early gestational age to 
identify the exact location of placenta previa. Efforts 
should be made to reduce the rate of pregnancy and 
cesarean deliveries by improving the provision of 
family planning to decrease the magnitude of pla-
centa previa. 
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